Get the Stockscreener App
101.57
1.06%
-1.12
Zimmer Biomet Holdings Inc stock is traded at $101.57, with a volume of 1.28M.
It is down -1.06% in the last 24 hours and down -1.48% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$102.69
Open:
$102.94
24h Volume:
1.28M
Relative Volume:
0.85
Market Cap:
$20.44B
Revenue:
$7.60B
Net Income/Loss:
$1.08B
P/E Ratio:
19.31
EPS:
5.26
Net Cash Flow:
$1.26B
1W Performance:
-7.19%
1M Performance:
-1.48%
6M Performance:
-3.97%
1Y Performance:
-20.34%
1-Day Range:
$101.54
$103.30
1-Week Range:
$101.54
$108.89
52-Week Range:
$100.67
$133.90
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
101.61 | 20.44B | 7.60B | 1.08B | 1.26B | 5.26 |
|
ABT
Abbott Laboratories
|
129.28 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.61 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
393.06 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.97 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.25 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| May-21-24 | Upgrade | Argus | Hold → Buy |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2024 Earnings Call Transcript - Insider Monkey
Zimmer BiometAdding To The Growth Profile (NYSE:ZBH) - Seeking Alpha
Zimmer Biomet Holdings Inc (ZBH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Zimmer Biomet Reports Strong 2024 Financial Performance - TipRanks
Zimmer Biomet Holdings: Hold Rating Amid Competitive Concerns and Growth Projections - TipRanks
Zimmer Biomet Q4 2024 Earnings Preview - MSN
Wells Fargo Cuts Zimmer Biomet Price Target to $113 From $117 -February 06, 2025 at 03:04 pm EST - Marketscreener.com
Zimmer Biomet projects 3%-5% revenue growth for 2025 with over 50 product launches in 36 months - MSN
Why Is Zimmer Biomet Stock Trading Lower On Thursday? - Benzinga
Evercore ISI Adjusts Zimmer Biomet Price Target to $110 From $113, Maintains In Line Rating - Marketscreener.com
Earnings call transcript: Zimmer Biomet Q4 2024 sees strong sales growth - MSN
ZBH's Q4 Earnings Beat, Margins Contract, Stock Down in Premarket - Yahoo Finance
Zimmer Biomet beats The Street in Q4 - Mass Device
Investors Appear Satisfied With Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Prospects - Simply Wall St
Zimmer Biomet stock slips as outlook disappoints (ZBH:NYSE) - Seeking Alpha
Zimmer Biomet's Dollar Dilemma Dampens 2025 Profit Outlook - Finimize
Zimmer Biomet reports Q4 earnings beat, revenue up 4.3% - MSN
Zimmer Biomet forecasts 2025 profit below estimates - Reuters
Zimmer Biomet (NYSE:ZBH) Posts Q4 Sales In Line With Estimates By Stock Story - Investing.com Canada
Zimmer Biomet Q4 Adjusted Earnings, Net Sales Rise; Issues 2025 Guidance -February 06, 2025 at 07:35 am EST - Marketscreener.com
Zimmer Biomet Holdings Inc. Surpasses Q4 Estimates with $2.31 EPS and $2.023 Billion Revenue - GuruFocus.com
Zimmer Biomet earnings beat by $0.01, revenue topped estimates - Investing.com Canada
Zimmer Biomet reports Q4 earnings beat, revenue up 4.3% By Investing.com - Investing.com Australia
Zimmer: Q4 Earnings Snapshot -February 06, 2025 at 06:45 am EST - Marketscreener.com
Earnings Flash (ZBH) Zimmer Biomet Holdings Posts Q4 Adjusted EPS $2.31, vs. FactSet Est of $1.73 - Marketscreener.com
Zimmer Biomet Holdings, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Zimmer Biomet (ZBH) To Report Earnings Tomorrow: Here Is What To Expect - Barchart
Zimmer Biomet (ZBH) To Report Earnings Tomorrow: Here Is What To Expect By Stock Story - Investing.com Canada
Global Electrosurgery Generators Market on a Growth Trajectory, Expected to Reach USD 3,359.2 Million by 2035 | Future Market Insights, Inc. - GlobeNewswire Inc.
Zimmer Biomet to buy surgical device company Paragon 28 for $1.1B - MSN
Kempner Capital Management Inc. Buys 13,349 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
New Wave Wealth Advisors LLC Takes $257,000 Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Set to Report Q4 Earnings: What's in Store? - MSN
Sivik Global Healthcare LLC Sells 20,000 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
KBC Group NV Has $3.09 Million Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet to buy Paragon 28 for $1.1 billion - MSN
Robeco Institutional Asset Management B.V. Reduces Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Inlet Private Wealth LLC Invests $2.66 Million in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Stock Position Lessened by Costello Asset Management INC - MarketBeat
Everett Harris & Co. CA Reduces Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Bought by Deroy & Devereaux Private Investment Counsel Inc. - MarketBeat
Zimmer Biomet's rating and oultook affirmed at Moody's as Paragon 28 deal enhances growth and diversifies business - MSN
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives $124.11 Average Price Target from Brokerages - MarketBeat
Gries Financial LLC Invests $866,000 in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet to acquire Paragon 28 - Today's Medical Developments
Zimmer Biomet (NYSE:ZBH) Earns Hold Rating from Needham & Company LLC - MarketBeat
Matrix Asset Advisors Inc. NY Has $9.53 Million Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Paragon 28, Inc. -January 31, 2025 at 04:26 pm EST - Marketscreener.com
Zimmer Biomet Stock Price | ZBH Stock Quote, News, and History - Markets Insider
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.33%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):